KROS Past Earnings

— Presenting past earnings and revenue for Keros Therapeutics (KROS) from Q1 2020 to Q4 2025. The past earnings numbers are per-share values while the revenue is the grand total for the quarter. Studying these KROS past earnings numbers both in chart format and in tables can help investors visualize any typical seasonality patterns, as well as determine whether the company has grown over time.

KROS Past Earnings Q&A

On this page we presented the KROS past earnings date information for Keros Therapeutics. Reviewing that KROS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2025, when KROS posted gaap of 3.620/share. Meanwhile the lowest KROS past earnings result was in Q1 2020, when KROS posted gaap of -5.110/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2025 when KROS reported 0.21B in revenue, while the smallest revenue quarter was Q2 2023 when KROS reported NA in revenue.

Any self directed investor doing their due diligence on KROS or any other given stock can benefit from researching all of the Keros Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Keros Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KROS. Thanks for visiting, and the next time you need to research KROS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.